|
| Status |
Public on Jan 31, 2008 |
| Title |
045_03_06 |
| Sample type |
RNA |
| |
|
| Source name |
Pre-treatment metastatic biopsy of CRC
|
| Organism |
Homo sapiens |
| Characteristics |
Tissue: Colon
|
| Extracted molecule |
total RNA |
| Extraction protocol |
RNA isolated from core-needle biopsy stored in RNAlater at RT using RNeasy Mini Kit (Qiagen)according to the manufacturer's instructions.
|
| Label |
biotin
|
| Label protocol |
Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 1 microg total RNA RNA!Sample_hyb_protocol = Standard Affymetrix procedures
|
| |
|
| Scan protocol |
GeneChips were scanned using the Affymetrix GeneChip Scanner 3000
|
| Description |
Gene expression data from pre-cetuximab monotherapy treatment biopsies of advanced metastatic colorectal cancer patients
|
| Data processing |
Data scaled to 1500 mean signal intensity value using GCOS 1.1.1.052
|
| |
|
| Submission date |
Sep 15, 2006 |
| Last update date |
Aug 28, 2007 |
| Contact name |
Shirin Khambata Ford |
| E-mail(s) |
shirin.ford@bms.com
|
| Organization name |
Bristol-Myers Squibb Pharmaceutical Research Institute
|
| Street address |
311 Pennington-Rocky Hill Road, 3B-2.06
|
| City |
Pennington |
| State/province |
NJ |
| ZIP/Postal code |
08534 |
| Country |
USA |
| |
|
| Platform ID |
GPL571 |
| Series (1) |
| GSE5851 |
Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
|
